Skip to main content
. 2019 Jun 28;98(26):e15954. doi: 10.1097/MD.0000000000015954

Figure 2.

Figure 2

Transcript expression of PDX1 and MSX2 in circulating blood samples were evaluated in pancreatic cancer (PC) and non-PC subjects (A, B), and in PC patients diagnosed with benign pathology (BP) and malignant pathology (MP) (C, D). The plots represent the median and percentile (25–75%) for comparisons between the indicated groups for PDX1 (A, C) and MSX2 (B, D). Data were evaluated using the nonparametric t test and the Mann–Whitney post-hoc test; P < .05, P < .01.